Phase I clinical trial of a recombinant canarypoxvirus (ALVAC) vaccine expressing human carcinoembryonic antigen and the B7.1 co-stimulatory molecule.

H Hörig; D S Lee; W Conkright; J Divito; H Hasson; M LaMare; A Rivera; D Park; J Tine; K Guito

doi:10.1007/s002620000146

Phase I clinical trial of a recombinant canarypoxvirus (ALVAC) vaccine expressing human carcinoembryonic antigen and the B7.1 co-stimulatory molecule.

NobleID: NI9P31W74R89S63
Persistent link: https://nobleid.org/ark:/48914/w1/20260515/E28F09CD

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/E28F09CD.svg?ark=w1%2F20260515%2FE28F09CD&value=id)](https://nobleid.org/work/w1/20260515/E28F09CD)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Phase I clinical trial of a recombinant canarypoxvirus (ALVAC) vaccine expressing human carcinoembryonic antigen and the B7.1 co-stimulatory molecule.

NobleID: NI9P31W74R89S63
Persistent link: https://nobleid.org/ark:/48914/w1/20260515/E28F09CD

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/E28F09CD.svg?ark=w1%2F20260515%2FE28F09CD&value=id)](https://nobleid.org/work/w1/20260515/E28F09CD)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work